ABIVAX Société Anonyme
ENXTPAABVX enters the week of August 12 with a striking divergence: the ORTEX short score has spiked sharply higher while the borrow market has moved in the opposite direction, loosening to its most accommodating level in months. The short score tells the most urgent story. It jumped from 57.4 on August 3 to 68.2 on August 11 — a move of nearly 11 points in less than two weeks. That…
Snapshot as of 27 Sept 2026
ABVX enters the week of August 12 with a striking divergence: the ORTEX short score has spiked sharply higher while the borrow market has moved in the opposite direction, loosening to its most accommodating level in…
ABIVAX's ABVX stock exploded 39% on June 30, its biggest single-session move in months, yet the lending market tells a story of shorts who aren't backing down. The catalyst appears to be continued momentum around the…
ABVX entered June with what should have been its finest hour. The Phase 3 ABTECT maintenance trial for obefazimod in ulcerative colitis met its primary endpoint. Instead, shares closed at €63.10 on June 2 — down 43.6%…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for ABVX — free to start on ORTEX.
Sign up for free →Open ABVX on ORTEX